Houlihan Lokey’s third quarter results outperformed Wall Street’s expectations, driven by a normalization of market activity and strength in its Corporate Finance segment. Management credited higher average transaction fees within mid-market deals for boosting revenues despite a decline in total transaction count. CEO Scott Adelson noted, “Our results for the quarter reflect a normalizing market environment,” while also highlighting growth across most industry groups except technology and health care, where performance remained subdued. The company’s restructuring business continued to face headwinds but showed signs of improvement as the pipeline began to rebuild.

Is now the time to buy HLI? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from Houlihan Lokey’s Q3 earnings call

• Brennan Hawken (BMO Capital Markets) asked about the impact of higher interest rates on deal activity. CEO Scott Adelson explained that mid-market transactions are less sensitive to rate changes, with capital availability outweighing rate concerns.
• Nathan Stein (Deutsche Bank) questioned the drop in transaction count versus higher revenues. CFO Lindsey Alley attributed this to a focus on larger, higher-fee deals and timing quirks, noting it may signal a longer-term shift toward more selective mandates.
• Devin Ryan (Citizens Bank) inquired about sector performance, especially technology and healthcare. Adelson said software remains challenged but is recovering, while healthcare’s weakness is more a timing issue than a structural decline.
• Gabriel Angelini (Bank of America) probed if outperformance would lead to above-average seasonality for the second half. Alley replied that the firm expects stronger than typical second-half performance, assuming market cooperation.
• Michael Brown (UBS) asked about the sponsor client segment’s role in deal momentum. Adelson confirmed that sponsors remain Houlihan Lokey’s largest client base and are showing increased willingness to transact as conviction grows.

Catalysts in upcoming quarters

In future quarters, the StockStory team will be monitoring (1) growth in restructuring mandates, particularly in software and European markets; (2) the effectiveness of Houlihan Lokey’s strategy to target higher-fee, high-probability deals; and (3) integration progress following the Intrepid Financial Partners acquisition. Additional attention will be paid to the resilience of the portfolio valuation business as market conditions evolve.

Houlihan Lokey currently trades at $137.18, in line with $137.38 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).

Our favorite stocks right now

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.